http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104502603-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2014-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104502603-B |
| titleOfInvention | MYO1D closes or open mark as diagnosis arterial duct |
| abstract | The present invention relates to MYO1D to close or open mark as diagnosis arterial duct.The method of the present invention ITRAQ proteomics carries out identification and analysis to open and closed human artery tracheal tissue, filter out 132 discrepant albumen, after carrying out signal path analysis, select MYO1D albumen, do you use western? blot, Qrt-PCR and SABC three kinds of methods are identified, prove that this albumen is expressed in human artery tracheal tissue first, and this albumen has obvious difference at two groups of closed and open arterial duct tissues, may be that regulation and control arterial duct closes or open key factor, can be used for the clinical diagnosis of patent ductus arteriosus, and the accuracy of diagnosis is high. |
| priorityDate | 2014-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.